70771-1708 BORTEZOMIB

Product NDC:

70771-1708

Brand Name:

BORTEZOMIB

Generic Name:

BORTEZOMIB

Dosage Form Name:

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Administration Route:

Intravenous

Subcutaneous

Substances:

Name: BORTEZOMIB

Strength: 1.0

Unit: mg/mL

Packages:

Code: 70771-1708-01

Description: 1 VIAL, SINGLE-DOSE in 1 CARTON (70771-1708-1) / 3.5 mL in 1 VIAL, SINGLE-DOSE

Effective Date: May 2, 2022

Discontinued:

SEER*Rx Category:

Chemotherapy

Major Class:

Proteasome Inhibitor

Minor Class:

26S

Orphan Drug Designation:

Status:

In Use

CanMED and the Oncology Toolbox